<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30028961</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1096-0945</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>105</Volume>                    <Issue>2</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Experimental and molecular pathology</Title>                <ISOAbbreviation>Exp. Mol. Pathol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.</ArticleTitle>            <Pagination>                <MedlinePgn>166-174</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0014-4800(18)30102-3</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.yexmp.2018.07.007</ELocationID>            <Abstract>                <AbstractText>In the late stages of their development, cancers can form metastases. Formation of metastases was found to be associated with the capacity of cancer cells to quit the tumor mass and journey through the circulation to distant organs. This cell population is called circulating tumor cells (CTCs). They exhibit several advanced properties such as epithelial-to-mesenchymal transition (EMT) and dormancy that are essential for supporting their survival in the bloodstream, radio- and chemoresistance, their escape from the anti-cancer immune response, and metastasis initiation. CTCs, and especially dormant tumor cells, are responsible for post-surgery tumor recurrence. CTCs were detected in the blood of patients affected with glioblastoma multiforme (GBM)-the most frequent, invasive, and deadly neoplasm among primary brain tumors. The identification of glioblastoma CTCs might have a promising clinical potential for early tumor diagnosis and prognosis. A variety of CTC enrichment and detection techniques have been developed to date. For several epithelial cancers, especially for breast carcinoma, a prognostic value of CTCs was reported. Similar efforts should be performed for GBM to evaluate clinical the significance of CTCs.</AbstractText>                <CopyrightInformation>Copyright Â© 2018 Elsevier Inc. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Chistiakov</LastName>                    <ForeName>Dimitry A</ForeName>                    <Initials>DA</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Basic and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Kropotkinsky Pereulok 23, 119991 Moscow, Russia. Electronic address: dimitry.chistiakov@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chekhonin</LastName>                    <ForeName>Vladimir P</ForeName>                    <Initials>VP</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Basic and Applied Neurobiology, V. P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Kropotkinsky Pereulok 23, 119991 Moscow, Russia; Department of Medical Nanobiotechnology, N. I. Pirogov Russian State Medical University (RSMU), Ulitsa Ostrovityanova 1, 117997 Moscow, Russia.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Exp Mol Pathol</MedlineTA>            <NlmUniqueID>0370711</NlmUniqueID>            <ISSNLinking>0014-4800</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Circulating tumor cells</Keyword>            <Keyword MajorTopicYN="N">Dormancy</Keyword>            <Keyword MajorTopicYN="N">Enrichment techniques</Keyword>            <Keyword MajorTopicYN="N">Epithelial-to-mesenchymal transition</Keyword>            <Keyword MajorTopicYN="N">Glioblastoma multiforme</Keyword>            <Keyword MajorTopicYN="N">Metastasis</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30028961</ArticleId>            <ArticleId IdType="pii">S0014-4800(18)30102-3</ArticleId>            <ArticleId IdType="doi">10.1016/j.yexmp.2018.07.007</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>